Source disclosure: February 12, 2026
Human Metabolome Technologies,Inc. [6090.T]
TOKYO, Feb 12 (Pulse News Wire) – Human Metabolome Technologies,inc. (6090.T) announced today that its board of directors has approved a share buyback program aimed at enhancing capital efficiency and responding to changes in the operating environment.
The decision was made based on the company's articles of incorporation, which allow for such actions under Article 165, Paragraph 3 of the Companies Act. Under the program, up to 250,000 shares (representing 4.4% percent of outstanding shares excluding treasury stock) will be purchased at a total cost not exceeding ¥200 million.
The buyback will take place through open-market purchases on the Tokyo Stock Exchange from February 13, 2026 to December 31, 2026. As of December 31, 2025, the company had 292,218 treasury shares out of a total of 5,627,579 outstanding shares excluding treasury stock.
This initiative underscores the company’s commitment to optimizing its capital structure and returning value to shareholders.
AI-translated content. 🟢 Confidence: High See terms • Original filing